Finding the silver lining about coronavirus pandemic
As India Pharma Inc reels under the far-reaching impact of the coronavirus epidemic, industry experts suggest policy reforms to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
China
Lessons from COVID-19
Policymakers will have to balance incentives for the pharma sector to scale up production with strict monitoring on environmental…
With China being hit by virus, India should look at positioning itself as alternative supply source
industry body Ficci pitched for incentivising local manufacturers to exhort them towards making investments and tackle supply…
Indian generic drugmakers may face supply shortages from China if coronavirus drags on
Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China…
Novel drug target may lead to universal antiviral vaccine
Researchers suggest that boosting levels of AGO4 could shore up the immune system to protect against multiple viruses
A…
2019-nCoV must reform India Pharma Inc
Urgent regulatory reform is needed to spur more proactive policies for proposed bulk drug and API parks which will make the…
Prolongation of coronavirus outbreak in China could hit Indian pharma sector
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million
Switzerland’s Obseva eyes China re-start for fertility drug that failed trial
In November last year, ObsEva said it was scrapping a development programme for nolasiban to help women undergoing in-vitro…
IMCD opens three new centres in India, China, Southeast Asia
The move adds to the company's further expansion of global network in the Asia Pacific region
Drugmakers slash prices in China to get on reimbursement list
Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis…